Spyre Therapeutics (SYRE) Interest & Investment Income (2015 - 2026)
Spyre Therapeutics (SYRE) reported Interest & Investment Income of $10.63 million for Q3 2026, up 97.5% from $5.38 million a year earlier and up 5.7% from the prior quarter.
Powered by 
Analysis
Spyre Therapeutics (SYRE) Interest & Investment Income (2015 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Spyre Therapeutics' Interest & Investment Income came in at $34.81 million, up 48.0% year-over-year; for FY2025, it was $24.89 million, up 16.8% from FY2024.
- Interest & Investment Income has increased for four consecutive years, with a five-year compound annual growth rate of 111.1% (FY2020 to FY2025).
- By year, Interest & Investment Income came in at $21.31 million in FY2024 (+246.7%), $6.15 million in FY2023 (+634.4%), $837,000 in FY2022 (+654.1%) and $111,000 in FY2021 (-81.3%).
- The Q3 2026 figure ranks as the highest quarterly Interest & Investment Income in data going back to Q1 2015.
- Year over year, Interest & Investment Income has now increased in each of the last five quarters, with growth averaging 36.2% over the last eight quarters.
- The high point for year-over-year Interest & Investment Income in five years was Q1 2024 (growth of 955.2%); the low point was Q4 2021 (a decline of 22.7%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $10.05 million (Q2 2026), $7 million (Q1 2026) and $7.14 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 67.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Spyre Therapeutics | 9.40 Bn | 5.68 Bn | - | 10.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 10.63 Mn |
| Jun 30, 2026 | 10.05 Mn |
| Mar 31, 2026 | 7.00 Mn |
| Dec 31, 2025 | 7.14 Mn |
| Sep 30, 2025 | 5.38 Mn |
| Jun 30, 2025 | 5.87 Mn |
| Mar 31, 2025 | 6.49 Mn |
| Dec 31, 2024 | 5.78 Mn |
| Sep 30, 2024 | 5.18 Mn |
| Jun 30, 2024 | 5.92 Mn |
| Mar 31, 2024 | 4.43 Mn |
| Dec 31, 2023 | 4.13 Mn |
| Sep 30, 2023 | 1.25 Mn |
| Jun 30, 2023 | 350,000.00 |
| Mar 31, 2023 | 420,000.00 |
| Dec 31, 2022 | 410,000.00 |
| Sep 30, 2022 | 288,000.00 |
| Jun 30, 2022 | 104,000.00 |
| Mar 31, 2022 | 35,000.00 |
| Dec 31, 2021 | 34,000.00 |
API Access
Spyre Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=SYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "SYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=SYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();